immune system

Immune System Overview and Leukocyte Classification

• Primary Function of the Immune System:

  • Serves as the body's defense mechanism against pathogens, viruses, bacteria, and foreign invaders.

  • Prevents lethal opportunistic infections; a decline in functional immune cell counts directly correlates with increased vulnerability to severe infection and death.

  • Relies on white blood cells (leukocytes) and specialized lymphoid tissues to coordinate defense responses.

• Leukocyte Production:

  • All white blood cells and red blood cells are manufactured within the bone marrow.

• General Classification of Leukocytes:

  • Lymphocytes: Specialized immune cells responsible for adaptive immunity and targeted defense.

  • Neutrophils: Phagocytic cells involved in immediate, non-specific defensive responses.

  • Monocytes: Large phagocytic cells that transition into tissue macrophages.

T Cell and B Cell Lymphocyte Subtypes

• T Cell Lymphocytes (Cell-Mediated Immunity):

  • Maturation: Produced in the bone marrow; migrate to the thymus gland (located in the neck, directly below the thyroid gland) to undergo maturation.

  • Function: Act as primary coordinators ("generals") of the immune response, distinguishing foreign antigens from self-antigens.

  • Clinical Significance: T cell counts (specifically CD4 helper cells) drop in HIV/AIDS, depriving the body of immune signaling.

  • Regulator T Cells:

    • Helper T Cells: Function as body scanners. They scan tissues, recognize antigens on viruses or bacteria, and trigger immune activation. They stimulate B cells to produce antibodies. Without helper T cells, the body cannot recognize invaders or produce target antibodies.

    • Suppressor T Cells: Act as an on/off switch for the immune response. They shut down immune activity once an infection is cleared. Malfunction or failure of suppressor T cells leads to autoimmune disorders (e.g., Rheumatoid Arthritis, Systemic Lupus Erythematosus, Ankylosing Spondylitis), where the immune system continuously attacks healthy self-tissue.

  • Effector T Cells:

    • Cytotoxic T Cells (Cytotoxins): Directly bind to and destroy invading cellular targets. They stimulate the release of lymphokines, which act as chemical messengers to coordinate local immune responses.

• B Cell Lymphocytes (Humoral Immunity):

  • Activation: Activated only after helper T cells scan and identify foreign antigens.

  • Plasma Cells: Specialized B cells that synthesize and secrete antigen-specific antibodies (immunoglobulins).

  • Memory Cells: Store antigenic information following an exposure or vaccination (e.g., COVID-19 vaccine). Upon re-exposure to the same antigen, memory cells rapidly convert into antibody-producing plasma cells to neutralize the invader before illness occurs.

Phagocytes, Natural Killer Cells, and Lymphoid Tissues

• Phagocytic Leukocytes:

  • Neutrophils (Microphages): Perform phagocytosis on a microscopic level, engulfing bacteria and cellular debris.

  • Monocytes (Macrophages): Large-scale phagocytes that engulf and digest foreign materials and bacteria.

  • Mechanism of Action: Phagocytosis operates like an engulfing process, consuming pathogens without initiating antibody production or scanning for systemic antigens.

  • Anatomical Distribution: Found throughout the body, including the brain, lungs, liver, spleen, kidneys, blood, and joint spaces.

  • Pathology: Pathological accumulation of neutrophils and monocytes in joint spaces, combined with suppressor T cell dysfunction, results in autoimmune joint destruction (e.g., Rheumatoid Arthritis in peripheral joints, Ankylosing Spondylitis in the spine).

• Natural Killer (NK) Cells:

  • Morphologically resemble lymphocytes but function distinctly within innate immunity.

  • Circulate continuously through the bloodstream to detect and eliminate virus-infected cells and malignant cells.

  • Release cytotoxic chemicals to dissolve targets upon contact.

  • Oncological Escape: Cancer cells can evade NK cell surveillance, allowing uninhibited cellular proliferation, tumor formation, and metastasis.

• Lymphoid Tissues and Structures:

  • Thymus Gland: Situated in the neck inferior to the thyroid; essential for T cell maturation.

  • Tonsils: Serve as a primary lymphoid barrier at the upper respiratory entry. Surgical removal (tonsillectomy) can increase susceptibility to upper respiratory infections such as strep throat and tonsillitis.

  • Spleen and Lymph Nodes: Filter pathogens and store leukocytes. Lymph nodes swell during active infections due to leukocyte accumulation. Lymph node enlargement lasting for weeks or months requires clinical evaluation to rule out lymphoma.

Immunoglobulins, Sleep Physiology, and Immunity Types

• Immunoglobulin Classes (Antibodies):

  • Antibodies are serum proteins produced by plasma B cells that bind specifically to target antigens.

  • $\text{IgG}$: Represents the highest percentage of circulating antibodies in the body.

  • $\text{IgA}$: Found in mucosal secretions and fluids.

  • $\text{IgM}$: Involved in primary immune responses.

  • $\text{IgD}$: Functions in B cell antigen recognition.

  • $\text{IgE}$: Present in the lowest percentage under normal conditions. Triggers the release of vasoactive chemicals (such as histamine) during allergic or inflammatory reactions. Hyperactivation leads to severe allergic responses or anaphylaxis.

• Sleep-Wake Cycles and Immunity:

  • Immune function is regulated by a $\text{24-hour}$ circadian sleep-wake rhythm.

  • Cellular repair and immune barrier building occur primarily during sleep.

  • Sleep deprivation (common in nursing students or hospitalized patients subjected to frequent routine interruptions) depresses the immune response, increasing susceptibility to opportunistic infections and colds.

• Classifications of Immunity:

  • Naturally Acquired Active Immunity: Achieved when the body contracts an infection naturally (e.g., chickenpox) and produces its own specific antibodies.

  • Artificially Acquired Active Immunity: Achieved through vaccination, prompting the body to actively manufacture targeted antibodies.

  • Passive Immunity: Acquired by transferring pre-formed, ready-made antibodies into the body (e.g., maternal antibodies passed to a infant through breast milk). Provides immediate protection that is short-lived, decaying over weeks to several months.

Inflammatory and Autoimmune Joint Disorders

• Inflammatory Response Mechanics:

  • Serves as a protective mechanism triggered by tissue trauma or pathogens.

  • Characterized by localized vasodilation, hyperperfusion, and fluid accumulation, manifesting as redness, heat, swelling, and pain.

  • Facilitates the delivery of nutrients, fluid, and leukocytes to injured sites for repair.

• Temporomandibular Joint (TMJ) Disorder:

  • Deterioration of the fibrocartilaginous disc cushion located between the temporal bone and the mandible.

  • Manifests as severe joint pain, local clicking/crepitus during movement, and impairment in chewing and speaking.

• Gout:

  • Metabolic inflammatory joint disease caused by hyperuricemia (elevated serum uric acid).

  • Dietary Triggers: High-purine foods including alcohol, organ meats (liver), sardines, shellfish, and red meat (steak).

  • Pharmacotherapy: Managed with uric acid synthesis inhibitors such as Allopurinol, alongside NSAIDs for acute flares.

• Ankylosing Spondylitis:

  • Inflammatory arthritis targeting the axial skeleton, particularly the lumbar spine and sacroiliac joints.

  • Loss of intervertebral cushioning leads to bony fusion (ankylosis) of the vertebrae.

  • Manifests as a rigid, forward-stooped posture, severely limiting spinal mobility, restricting diaphragmatic excursion during respiration, and predisposing patients to secondary cardiovascular complications.

Rheumatoid Arthritis and Osteoarthritis

• Rheumatoid Arthritis (RA):

  • Pathophysiology: Chronic, systemic autoimmune inflammatory disorder. B cells produce autoantibodies (Rheumatoid Factor) that attack self-immunoglobulins ($\text{IgG}$) in the synovial tissue.

  • Disease Progression: Synovitis leads to vasodilation, severe congestion, and the formation of a destructive pannus (vascular granulation tissue) that erodes articular cartilage and underlying bone.

  • Diagnostic Findings: $\text{70\% to 80\%}$ positive for Rheumatoid Factor (RF); elevated C-Reactive Protein (CRP), Antinuclear Antibody (ANA), and Erythrocyte Sedimentation Rate (ESR); leukocytosis; cloudy, crystal-containing synovial fluid upon aspiration.

  • Clinical Presentation: Symmetric joint swelling, warmth, morning stiffness, and progressive joint deformities such as swan-neck deformities of the digits.

• Osteoarthritis (OA):

  • Pathophysiology: Non-autoimmune, progressive degenerative joint disease characterized by wear-and-tear destruction of the articular cartilage at bone ends.

  • Mechanics: Cartilage loss leads to direct bone-on-bone friction, subchondral sclerosis, bone cyst formation, and marginal osteophyte (bone spur) development.

  • Clinical Presentation: Asymmetric pain exacerbated by weight-bearing activity, joint stiffness, movement limitations, and crepitus (a crunching or grating sound/sensation during joint motion).

  • Bony Nodules: Formation of Heberden's nodes (distal interphalangeal joints) and Bouchard's nodes (proximal interphalangeal joints).

  • Risk Factors: Advanced age, repetitive trauma/sports injuries, genetic predisposition, poor posture, joint malalignment, sedentary lifestyle/obesity, cardiovascular disease, diabetes mellitus, and hemochromatosis (iron overload, common in individuals over $\text{60 years}$ of age).

Arthrocentesis and Pharmacological Interventions

• Arthrocentesis Procedure:

  • Ultrasound-guided diagnostic and therapeutic aspiration of synovial fluid from an inflamed joint capsule (e.g., knee joint).

  • Procedural Steps:

    1. Perform preliminary ultrasound scan in transverse and cross-sectional planes to locate joint effusion (e.g., beneath the quadriceps tendon above the patella) and avoid vascular structures.

    2. Cleanse skin using chlorhexidine.

    3. Infiltrate local cutaneous tissue with lidocaine for anesthesia.

    4. Insert an $\text{18-gauge}$ needle into the central effusion zone under continuous visual guidance and aspirate fluid.

    5. Fluid is analyzed for leukocytes, crystals, pathogens, and Rheumatoid Factor.

    6. Intra-articular corticosteroids may be injected directly into the joint space post-aspiration to suppress local inflammation.

• Rheumatoid Arthritis Pharmacotherapy:

  • NSAIDs & Corticosteroids (e.g., Prednisone): Provide acute anti-inflammatory and analgesic control.

  • Disease-Modifying Antirheumatic Drugs (DMARDs):

    • Methotrexate: Immunosuppressive cytotoxic agent that dampens autoimmune inflammatory cascades.

    • Hydroxychloroquine (Plaquenil): Long-term DMARD. Requires mandatory ophthalmological monitoring due to the potential risk of irreversible retinal damage and vision loss.

    • Humira (Adalimumab): Biologic DMARD targeting inflammatory cytokines; costly (approximately $\text{3,000 USD per month}$ without coverage).

  • Plasmapheresis: Therapeutic blood filtration procedure where blood is removed, spun to separate plasma from cellular components, and filtered to remove autoimmune antibodies before reinfusing the cells back into the body.

  • RA Nursing Care Standards: Physical Therapy (PT) and fall risk precautions are indicated to maintain mobility and safety. Bed rest is strictly contraindicated, as immobility accelerates joint stiffness and muscle atrophy.

Systemic Lupus Erythematosus (SLE) and Discoid Lupus Erythematosus (DLE)

• Discoid Lupus Erythematosus (DLE):

  • Benign, cutaneous-limited form of lupus.

  • Manifests as scaly, erythematous, raised skin lesions (frequently mimicking eczema) and mucosal ulcers in the mouth and nose.

  • Does not affect internal visceral organs, though it can occasionally progress to systemic involvement.

• Systemic Lupus Erythematosus (SLE):

  • Severe, multisystem chronic autoimmune disease where autoantibodies attack connective tissue throughout the entire body.

  • Target Organs: Affects kidneys, heart, lungs, vascular system, joints, skin, and central nervous system. Patients are at elevated risk for catastrophic cardiovascular events, including myocardial infarction and cerebrovascular accidents (stroke).

  • Classic Pathognomonic Sign: A distinct butterfly (malar) rash extending across the cheeks and the bridge of the nose.

  • Exacerbation Triggers: Exposure to ultraviolet light/sunlight, physical or emotional stress, hormonal fluctuations, toxic exposures, and viral infections (e.g., Epstein-Barr virus).

  • Patient Education: Stringent application of high-SPF sunscreen, wearing protective long-sleeved clothing outdoors, avoiding direct sun exposure, managing stress, and adhering to prescribed immunosuppressant therapy.

Peritonitis and Dialysis Modalities

• Pathophysiology of Peritonitis:

  • Acute inflammation and infection of the peritoneum—the serous membrane lining the abdominal cavity and covering visceral organs.

  • Etiologies: Abdominal trauma, ruptured appendix, liver cirrhosis with ascites, visceral perforation, and bacterial contamination during peritoneal dialysis.

• Clinical Presentation:

  • Severe diffuse abdominal pain, localized rebound tenderness, board-like abdominal rigidity, involuntary guarding, nausea, vomiting, constipation, fever, leukocytosis, and severe hypotension progressing to septic shock.

• Peritoneal Dialysis (PD) vs. Hemodialysis (HD):

  • Hemodialysis (HD): Extracorporeal filtration performed via vascular access (AV fistula, synthetic graft, or central venous catheter). Blood passes through an external dialyzer containing dialysate fluid across a semipermeable membrane using diffusion/osmosis. Administered $\text{3 times per week}$ for $\text{4 hours}$ per session. Requires anticoagulation (e.g., heparin) to prevent clotting.

  • Peritoneal Dialysis (PD): Uses the patient's peritoneal membrane as a natural filter. Dialysate solution is instilled into the peritoneal cavity via an indwelling abdominal catheter, dwells for several hours to absorb nitrogenous waste and fluid, and is then gravity-drained.

  • PD Complications: Highly prone to peritonitis due to line contamination. Manifests as cloudy dialysate effluent, abdominal pain, fever, and systemic sepsis.

Bone, Infectious, and Central Nervous System Disorders

• Osteomyelitis:

  • Severe, deep-seated bacterial bone infection, most frequently caused by Staphylococcus aureus (gram-positive pathogen).

  • Results from open wound extension or hematogenous spread. Manifests as severe bone pain and chronic purulent sinus tract drainage. Treated with surgical debridement and Dakin's solution (a sodium hypochlorite/bleach-based antiseptic wash).

• Osteoporosis:

  • Metabolic bone disease characterized by loss of bone mass and porous, brittle bone matrix.

  • Driven by post-menopausal estrogen declines (notably within $\text{25 years}$ post-menopause), placing patients at high risk for low-trauma fractures and height loss.

• Osteomalacia:

  • Metabolic bone disorder causing progressive softening of the skeleton due to severe, chronic Vitamin D deficiency.

• Hammertoe and Bunions:

  • Foot joint deformities resulting from repetitive mechanical impact, tight footwear, or sports trauma (common in skateboarders).

• Influenza and Infection Control:

  • Viral respiratory infection transmitted via droplets. Surgical masks represent the primary essential PPE barrier to prevent transmission.

• Meningitis:

  • Acute inflammation of the meninges surrounding the brain and spinal cord, specifically affecting the subarachnoid space.

  • Bacterial meningitis is significantly more severe and life-threatening than viral meningitis.

  • Diagnosis: Diagnosed via a lumbar puncture (spinal tap) aspirating cerebrospinal fluid (CSF) from the subarachnoid space for culture, protein, and glucose analysis.

Clinical Review and Self-Assessment Diagnostics

• Diagnostic Question 1: Which cell type performs phagocytosis to digest bacteria and foreign material?

  • Answer: Neutrophils (microphages) and Monocytes (macrophages).

• Diagnostic Question 2: Which specific lymphocyte subtype synthesizes and secretes protective serum antibodies?

  • Answer: Plasma B cells.

• Diagnostic Question 3: Which class of immunoglobulins mediates allergic responses and histamine release?

  • Answer: $\text{IgE}$.

• Diagnostic Question 4: What category of immunity is conferred through administration of a viral vaccine?

  • Answer: Artificially acquired active immunity.

• Diagnostic Case Analysis (Rheumatoid Arthritis Suspected):

  • Patient Scenario: $\text{37-year-old}$ female presenting with a $\text{2-month}$ history of bilateral joint pain, persistent hand swelling, tenderness, and thumb curvature deformities.

  • Anticipated Diagnostic Lab Results:

    • Rheumatoid Factor (RF): Positive.

    • Erythrocyte Sedimentation Rate (ESR): Elevated.

    • C-Reactive Protein (CRP): Positive/Elevated.

    • Antinuclear Antibody (ANA): Positive.

    • Complete Blood Count (CBC): Leukocytosis (elevated WBCs).

  • Plan of Care Evaluation:

    • Physical Therapy (PT): Indicated.

    • Fall Precautions: Indicated.

    • NSAIDs / DMARDs / Corticosteroids: Indicated.

    • Strict Bed Rest: Contraindicated (promotes joint ankylosis and muscle wasting).